Erscheinungsjahr
Datenquelle
Sprache
1–20 von 111 Ergebnissen
Sortieren:
Sortieren:
-
A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population
Wiley | 2020|Schlagwörter: Radium‐223 -
Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA
Wiley | 2016|Schlagwörter: radium‐223 -
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
Online Contents | 2020|Schlagwörter: Radium 223 -
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
Freier ZugriffOnline Contents | 2018|Schlagwörter: Radium-223 dichloride -
Combination treatment in metastatic castration-resistant prostate cancer: can we safely boost efficacy by adding radium-223?
Freier ZugriffTaylor & Francis Verlag | 2020|Schlagwörter: radium-223 -
Radium-223 dichloride in clinical practice: a review
Online Contents | 2016|Schlagwörter: Radium-223 dichloride -
Current perspectives on bone metastases in castrate-resistant prostate cancer
Freier ZugriffOnline Contents | 2018|Schlagwörter: Radium-223 -
Radium-223 dichloride for the treatment of metastatic prostate cancer
Taylor & Francis Verlag | 2014|Schlagwörter: radium-223 -
Cherenkov light production from the α-emitting decay chains of 223Ra, 212Pb, and 149Tb for Cherenkov Luminescence Imaging
Elsevier | 2016|Schlagwörter: Radium-223 -
Factors Influencing Outcome Post–Radium-223 Dichloride in Castrate Resistant Prostate Cancer: A Review of Some Real-World Challenges
Freier ZugriffThieme Verlag | 2022|Schlagwörter: Radium-223 -
Treatment landscape of metastatic prostate cancer: the role of radium-223
Taylor & Francis Verlag | 2017|Schlagwörter: Radium-223 -
Safety of concomitant therapy with radium‐223 and abiraterone or enzalutamide in a real‐world population
Wiley | 2021|Schlagwörter: radium‐223 -
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice
Freier ZugriffOnline Contents | 2019|Schlagwörter: Radium-223 -
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
Online Contents | 2017|Schlagwörter: Radium-223 -
Patterns of response and progression in bone and soft tissue during and after treatment with radium‐223 for metastatic castrate‐resistant prostate cancer
Wiley | 2019|Schlagwörter: radium‐223 -
A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer
Freier ZugriffOnline Contents | 2021|Schlagwörter: Radium-223 -
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Freier ZugriffOnline Contents | 2021|Schlagwörter: Radium-223 -
Radium-223 for the treatment of prostate cancer
Taylor & Francis Verlag | 2013|Schlagwörter: radium-223 -
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer
Taylor & Francis Verlag | 2015|Schlagwörter: radium-223 -
Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer
Online Contents | 2016|Schlagwörter: Radium-223 therapy